2018 should be great, but 2019 should be greater, and 2020 should be greater still. The point is, as we put products into the hands of consumers, sales will grow dramatically each year for the foreseeable future.
It will probably be at least 2020, and probably later than that before the first FDA approved drug developed by the company is on the market. Earnings should increase substantially once approved drugs become available, but by then most of us should be millionaires without it.
For now, I think we need to sit back and relax, and wait for news. News will come when the safety trial is complete, when other trials begin, and perhaps most importantly when a product goes on sale. Of course we'll also learn of any new collaboration the company establishes, and that could happen at any time.
From a percentage growth standpoint, 2018 will probably be our greatest year, it should be a multi-banger. It would take roughly a 15 banger to give us a billion dollar market cap, certainly that's possible, but would anyone really complain if we only did half that, I don't think so. By 2020 we could certainly have a few billion market cap giving us a share price of $20 or more, any complaint about that. Again I don't think so, but of course we could be substantially higher as well. It's all a matter of moving product into the marketplace, and having it accepted there.
If as I believe the sublingual tablet in many different formulation becomes the preferred way of administering cannabis, practically every cannabis store in the world will offer our product. In time it will be prescribed, and covered by insurance in practically all drug stores. No telling how high the market cap could be at that time, but double digit billions is certainly in the picture.
Happy New Year's,
Gary
